Diacerein Reduces Inflammasome Activation and SARS-CoV-2 Virus Replication: a Proof-of-concept Translational Study

Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is linked to high mortality, primarily through an intense inflammatory response. Diacerein has emerged as a potential therapy for COVID-19 due to its potential impact in decreasing the inflammasome activation and coronavirus replication. This study aims to explore diacerein's influence in inhibiting both viral replication and the inflammatory response after SARS-CoV-2 infection.

Methods: Human peripheral blood mononuclear cells (PBMCs) were obtained from healthy volunteers and infected with SARS-CoV-2. Additionally, we carried out a pilot randomized, double-blind, placebo-controlled study with 14 participants allocated to diacerein (n = 7) or placebo (n = 7) therapies every 12 h for 10 days. The primary endpoint was change in plasma markers of inflammasome activation (NLRP3, caspase-1, and gasdermin-D).

Results: protocols have shown that rhein, diacerein's primary metabolite, decreased IL-1β secretion caused by SARS-CoV-2 infection in human PBMCs ( < 0.05), and suppressed viral replication when administered either before or after the virus incubation ( < 0.05). This later effect was, at least partially, attributed to its inhibitory effect on 3-chymotrypsin-like protease (SARS-CoV-2 3CL) and papain-like protease in the SARS-CoV-2 (SARS-CoV-2 PL) virus and in the phosphorylation of proteins related cytoskeleton network ( < 0.05). Diacerein-treated COVID-19 patients presented a smaller area under the curve for NLRP3, caspase-1 and GSDM-D measured on days 2, 5, and 10 after hospitalization compared to those receiving a placebo ( < 0.05).

Conclusion: The indicated mechanisms of action of diacerein/rhein can reduce viral replication and mitigate the inflammatory response related to SARS-CoV-2. These findings are preliminary and require confirmation in clinical trials.

Citing Articles

Network pharmacology and molecular analysis of mechanisms underlying the therapeutic effects of Rhubarb in treating atherosclerosis and abdominal aortic aneurysm.

Xu H, Huang J, Zeng Y, Wang X, Lian H, Zhang S Heliyon. 2025; 11(4):e41906.

PMID: 40028580 PMC: 11867279. DOI: 10.1016/j.heliyon.2025.e41906.

References

Alcantara L, Nogueira E, Shuab G, Tosta S, Fristch H, Pimentel V . SARS-CoV-2 epidemic in Brazil: how the displacement of variants has driven distinct epidemic waves. Virus Res. 2022; 315:198785. PMC: 9022374. DOI: 10.1016/j.virusres.2022.198785. View

Lukhna K, do Carmo H, Castillo A, Davidson S, Geffen H, Giesz S . Effect of Remote Ischaemic Conditioning on the Inflammatory Cytokine Cascade of COVID-19 (RIC in COVID-19): a Randomized Controlled Trial. Cardiovasc Drugs Ther. 2022; 38(3):433-445. PMC: 9707178. DOI: 10.1007/s10557-022-07411-2. View

Khan M, Irfan M, Ahsan H, Ahmed A, Kaushik A, Khan A . Structures of SARS-CoV-2 RNA-Binding Proteins and Therapeutic Targets. Intervirology. 2021; 64(2):55-68. PMC: 7900486. DOI: 10.1159/000513686. View

Silva da Costa L, Outlioua A, Anginot A, Akarid K, Arnoult D . RNA viruses promote activation of the NLRP3 inflammasome through cytopathogenic effect-induced potassium efflux. Cell Death Dis. 2019; 10(5):346. PMC: 6483999. DOI: 10.1038/s41419-019-1579-0. View

Pan P, Shen M, Yu Z, Ge W, Chen K, Tian M . SARS-CoV-2 N protein promotes NLRP3 inflammasome activation to induce hyperinflammation. Nat Commun. 2021; 12(1):4664. PMC: 8329225. DOI: 10.1038/s41467-021-25015-6. View

. A minimal common outcome measure set for COVID-19 clinical research. Lancet Infect Dis. 2020; 20(8):e192-e197. PMC: 7292605. DOI: 10.1016/S1473-3099(20)30483-7. View

Zhu W, Xu M, Chen C, Guo H, Shen M, Hu X . Identification of SARS-CoV-2 3CL Protease Inhibitors by a Quantitative High-Throughput Screening. ACS Pharmacol Transl Sci. 2020; 3(5):1008-1016. PMC: 7507806. DOI: 10.1021/acsptsci.0c00108. View

Liu M, Wang L, Wu X, Gao K, Wang F, Cui J . Rhein protects 5/6 nephrectomized rat against renal injury by reducing inflammation via NF-κB signaling. Int Urol Nephrol. 2021; 53(7):1473-1482. DOI: 10.1007/s11255-020-02739-w. View

Kazmierski J, Friedmann K, Postmus D, Emanuel J, Fischer C, Jansen J . Nonproductive exposure of PBMCs to SARS-CoV-2 induces cell-intrinsic innate immune responses. Mol Syst Biol. 2022; 18(8):e10961. PMC: 9382356. DOI: 10.15252/msb.202210961. View

10.

Wang Q, Su Y, Sheng J, Gu L, Zhao Y, Chen X . Anti-influenza A virus activity of rhein through regulating oxidative stress, TLR4, Akt, MAPK, and NF-κB signal pathways. PLoS One. 2018; 13(1):e0191793. PMC: 5791991. DOI: 10.1371/journal.pone.0191793. View

11.

Manunta M, Lamorte G, Ferrari F, Trombetta E, Tirone M, Bianco C . Impact of SARS-CoV-2 infection on the recovery of peripheral blood mononuclear cells by density gradient. Sci Rep. 2021; 11(1):4904. PMC: 7921094. DOI: 10.1038/s41598-021-83950-2. View

12.

Henamayee S, Banik K, Sailo B, Shabnam B, Harsha C, Srilakshmi S . Therapeutic Emergence of Rhein as a Potential Anticancer Drug: A Review of Its Molecular Targets and Anticancer Properties. Molecules. 2020; 25(10). PMC: 7288145. DOI: 10.3390/molecules25102278. View

13.

Galluce Torina A, Reichert K, Lima F, de Souza Vilarinho K, Martins de Oliveira P, do Carmo H . Diacerein improves left ventricular remodeling and cardiac function by reducing the inflammatory response after myocardial infarction. PLoS One. 2015; 10(3):e0121842. PMC: 4376692. DOI: 10.1371/journal.pone.0121842. View

14.

Malathi K, Siddiqui M, Dayal S, Naji M, Ezelle H, Zeng C . RNase L interacts with Filamin A to regulate actin dynamics and barrier function for viral entry. mBio. 2014; 5(6):e02012. PMC: 4217177. DOI: 10.1128/mBio.02012-14. View

15.

Falavigna M, Belli K, Barbosa A, Zavascki A, Nastri A, Santana C . Brazilian guidelines for the treatment of outpatients with suspected or confirmed COVID-19. A joint guideline of the Brazilian Association of Emergency Medicine (ABRAMEDE), Brazilian Medical Association (AMB), Brazilian Society of Angiology and.... Braz J Infect Dis. 2022; 26(2):102347. PMC: 8926872. DOI: 10.1016/j.bjid.2022.102347. View

16.

Wen Z, Zhang Y, Lin Z, Shi K, Jiu Y . Cytoskeleton-a crucial key in host cell for coronavirus infection. J Mol Cell Biol. 2020; 12(12):968-979. PMC: 7454755. DOI: 10.1093/jmcb/mjaa042. View

17.

Rodrigues T, de Sa K, Ishimoto A, Becerra A, Oliveira S, Almeida L . Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients. J Exp Med. 2020; 218(3). PMC: 7684031. DOI: 10.1084/jem.20201707. View

18.

Zhou Y, Gao C, Vong C, Tao H, Li H, Wang S . Rhein regulates redox-mediated activation of NLRP3 inflammasomes in intestinal inflammation through macrophage-activated crosstalk. Br J Pharmacol. 2021; 179(9):1978-1997. DOI: 10.1111/bph.15773. View

19.

Li Z, Li L, Sun Y, Li J . Identification of natural compounds with anti-hepatitis B virus activity from Rheum palmatum L. ethanol extract. Chemotherapy. 2007; 53(5):320-6. DOI: 10.1159/000107690. View

20.

Dominguez I, Cruz-Gamero J, Corasolla V, Dacher N, Rangasamy S, Urbani A . Okur-Chung neurodevelopmental syndrome-linked CK2α variants have reduced kinase activity. Hum Genet. 2021; 140(7):1077-1096. DOI: 10.1007/s00439-021-02280-5. View